• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎儿血红蛋白水平或红细胞指数对镰状细胞贫血严重程度无影响。

Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.

作者信息

Powars D R, Schroeder W A, Weiss J N, Chan L S, Azen S P

出版信息

J Clin Invest. 1980 Mar;65(3):732-40. doi: 10.1172/JCI109720.

DOI:10.1172/JCI109720
PMID:6153392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC371416/
Abstract

Persons with sickle cell anemia who have elevated fetal hemoglobin or lowered erythrocyte mean corpuscular volume are reputed to have less severe clinical manifestations and a greater probability of survival. This study examines the relationship between seven clinical indicators of morbidity in sickle cell anemia and seven hematological parameters that were collected from 214 patients. Risks of sickle cell crisis, acute chest syndrome, hospital admissions, cerebrovascular accident, aseptic necrosis, meningitis/septicemia, and death were used as indicators of morbidity. The hematological parameters included percent fetal hemoglobin, absolute fetal hemoglobin, percent hemoglobin A2, hemoglobin concentration, packed cell volume, mean corpuscular volume, and mean corpuscular hemoglobin concentration. Statistical analyses of the data showed no relationship between the hematological parameters and six of the seven clinical indicators of the severity of sickle cell anemia. The only significant finding was an increased risk of stroke in those patients with lower levels of fetal hemoglobin. Therefore, with this exception, there is no predictable relationship between morbidity and mortality in sickle cell anemia and levels of fetal hemoglobin or erythrocyte indices. Thus, the general belief that there is an association between severity of sickle cell anemia and the levels of fetal hemoglobin has not been established.

摘要

患有镰状细胞贫血且胎儿血红蛋白升高或红细胞平均体积降低的人,据说其临床表现较轻,存活概率更大。本研究调查了从214名患者身上收集的镰状细胞贫血的七个发病临床指标与七个血液学参数之间的关系。镰状细胞危象、急性胸部综合征、住院、脑血管意外、无菌性坏死、脑膜炎/败血症和死亡的风险被用作发病指标。血液学参数包括胎儿血红蛋白百分比、绝对胎儿血红蛋白、血红蛋白A2百分比、血红蛋白浓度、红细胞压积、平均红细胞体积和平均红细胞血红蛋白浓度。数据的统计分析表明,血液学参数与镰状细胞贫血严重程度的七个临床指标中的六个没有关系。唯一显著的发现是胎儿血红蛋白水平较低的患者中风风险增加。因此,除了这个例外,镰状细胞贫血的发病率和死亡率与胎儿血红蛋白水平或红细胞指数之间没有可预测的关系。因此,镰状细胞贫血的严重程度与胎儿血红蛋白水平之间存在关联这一普遍观点尚未得到证实。

相似文献

1
Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.胎儿血红蛋白水平或红细胞指数对镰状细胞贫血严重程度无影响。
J Clin Invest. 1980 Mar;65(3):732-40. doi: 10.1172/JCI109720.
2
The interaction of alpha-thalassemia and homozygous sickle-cell disease.α地中海贫血与纯合子镰状细胞病的相互作用。
N Engl J Med. 1982 Jun 17;306(24):1441-6. doi: 10.1056/NEJM198206173062402.
3
Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.镰状细胞贫血与α地中海贫血并发:对贫血严重程度的影响。
N Engl J Med. 1982 Feb 4;306(5):270-4. doi: 10.1056/NEJM198202043060504.
4
Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.α地中海贫血改变镰状细胞病中的红细胞异质性。
J Clin Invest. 1985 May;75(5):1632-7. doi: 10.1172/JCI111870.
5
Pain in sickle cell disease. Rates and risk factors.镰状细胞病中的疼痛。发生率及危险因素。
N Engl J Med. 1991 Jul 4;325(1):11-6. doi: 10.1056/NEJM199107043250103.
6
The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia.镰状细胞贫血患儿中胎儿血红蛋白与疾病严重程度的关系。
Am J Med Genet. 1987 Jul;27(3):525-35. doi: 10.1002/ajmg.1320270305.
7
Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.羟基脲在成人镰状细胞贫血治疗中的作用机制。
Semin Hematol. 1997 Jul;34(3 Suppl 3):15-21.
8
Mortality in sickle cell disease. Life expectancy and risk factors for early death.镰状细胞病的死亡率。预期寿命和早期死亡的风险因素。
N Engl J Med. 1994 Jun 9;330(23):1639-44. doi: 10.1056/NEJM199406093302303.
9
Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.镰状细胞病中的羟基脲——对印度单倍型临床药理疗效的研究
Blood Cells Mol Dis. 2009 Jan-Feb;42(1):25-31. doi: 10.1016/j.bcmd.2008.08.003. Epub 2008 Oct 26.
10
Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.约旦北部患有镰状细胞病女童的急性脾滞留
J Trop Pediatr. 2006 Dec;52(6):416-20. doi: 10.1093/tropej/fml042. Epub 2006 Sep 2.

引用本文的文献

1
Neurological abnormalities among pediatric patients with sickle cell disease in Saudi Arabia: a single-center retrospective study.沙特阿拉伯镰状细胞病儿科患者的神经学异常:一项单中心回顾性研究。
Front Pediatr. 2024 Jan 10;11:1290314. doi: 10.3389/fped.2023.1290314. eCollection 2023.
2
Variation and impact of polygenic hematologic traits in monogenic sickle cell disease.单基因镰状细胞病中多基因血液特征的变化及其影响。
Haematologica. 2023 Mar 1;108(3):870-881. doi: 10.3324/haematol.2022.281180.
3
Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.印度中部镰状细胞病患儿的新生儿筛查及临床结局
PLoS One. 2016 Jan 19;11(1):e0147081. doi: 10.1371/journal.pone.0147081. eCollection 2016.
4
Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis.镰状细胞生物流变学的动力学及其对疼痛性血管闭塞危机的影响。
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1422-7. doi: 10.1073/pnas.1424111112. Epub 2015 Jan 20.
5
Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.沙特阿拉伯的镰状细胞病:具有阿拉伯-印度单倍型的成年人的表型并非良性。
Br J Haematol. 2014 Feb;164(4):597-604. doi: 10.1111/bjh.12650. Epub 2013 Nov 13.
6
Genetic modifiers of sickle cell disease.镰状细胞病的遗传修饰物。
Am J Hematol. 2012 Aug;87(8):795-803. doi: 10.1002/ajh.23232. Epub 2012 May 28.
7
The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.羟基脲治疗与门诊镰状细胞贫血患者疼痛强度、镇痛药物使用和利用之间的关联。
Pain Med. 2011 May;12(5):697-705. doi: 10.1111/j.1526-4637.2011.01096.x. Epub 2011 Apr 11.
8
Hydroxyurea for children with sickle cell disease.羟基脲治疗镰状细胞病儿童。
Hematol Oncol Clin North Am. 2010 Feb;24(1):199-214. doi: 10.1016/j.hoc.2009.11.002.
9
Sickle cell vasoocclusion: many issues and some answers.镰状细胞血管阻塞:诸多问题与一些答案
Experientia. 1993 Jan 15;49(1):5-15. doi: 10.1007/BF01928783.
10
Heterogeneity of sickle-cell anemia based on a profile of hematological variables.基于血液学变量概况的镰状细胞贫血异质性。
Am J Hum Genet. 1983 Nov;35(6):1224-40.

本文引用的文献

1
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN IN GREECE. A STUDY AND A COMPARISON.希腊胎儿血红蛋白的遗传性持续存在。一项研究与比较。
Blood. 1964 Sep;24:223-40.
2
Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 Negro families in Baltimore.胎儿血红蛋白遗传性持续存在:对巴尔的摩15个黑人家庭中79名患者的研究。
Blood. 1963 Mar;21:261-81.
3
[Demonstration of fetal hemoglobin in erythrocytes of a blood smear].[血涂片红细胞中胎儿血红蛋白的显示]
Klin Wochenschr. 1957 Jun 15;35(12):637-8. doi: 10.1007/BF01481043.
4
Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.不可逆镰状红细胞:镰状细胞贫血中血红蛋白类型异质分布的结果。
J Clin Invest. 1968 Aug;47(8):1731-41. doi: 10.1172/JCI105863.
5
Milder variant of sickle-cell disease in Arabs in Kuwait associated with unusually high level of foetal haemoglobin.科威特阿拉伯人中镰状细胞病的较轻变体与异常高水平的胎儿血红蛋白有关。
Br J Haematol. 1970 Nov;19(5):613-9. doi: 10.1111/j.1365-2141.1970.tb01645.x.
6
Hemoglobin interaction: modification of solid phase composition in the sickling phenomenon.血红蛋白相互作用:镰状化现象中固相成分的改变。
Science. 1970 Jul 24;169(3943):375-7. doi: 10.1126/science.169.3943.375.
7
Abnormal rheology of oxygenated blood in sickle cell anemia.镰状细胞贫血中氧合血液的流变学异常。
J Clin Invest. 1970 Apr;49(4):623-34. doi: 10.1172/JCI106273.
8
A new sickling disorder resulting from interaction of the genes for haemoglobin S and alpha-thalassaemia.一种由血红蛋白S基因与α地中海贫血基因相互作用导致的新型镰状细胞疾病。
Br J Haematol. 1969 Dec;17(6):517-26. doi: 10.1111/j.1365-2141.1969.tb01402.x.
9
Mild sickle cell disease. Clinical and laboratory studies.轻度镰状细胞病。临床与实验室研究。
JAMA. 1973 Apr 16;224(3):317-21.
10
Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.红细胞血红蛋白S浓度。镰状细胞贫血中血液低氧亲和力的一个重要因素。
J Clin Invest. 1973 Feb;52(2):422-32. doi: 10.1172/JCI107199.